PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation. Tissue-selective energy delivery and short application times offer ...
During pulsed field ablation (PFA) for atrial fibrillation (Afib or AF), the additional creation of mitral isthmus ablation lines often led to vasospasm of the neighboring left circumflex artery, ...
Healthcare - NORD Pipera Hospital, part of the MedLife Group, marks a national premiere in interventional cardiology for the treatment of atrial fibrillation through ...
Boston Scientific leads the pulsed field ablation (PFA) technology market to treat atrial fibrillation (Afib). But it is by no means alone in its commitment to this relatively new way to treat some ...
Amsterdam, Netherlands – 27 Aug 2023: Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late ...
The spotlight is now on Medtronic, as the medtech giant is the first to win FDA approval for a pulsed field ablation system (PFA). The Dublin-based company secures the nod before Boston Scientific ...
Boston Scientific announced today that its Farapulse pulsed-field ablation (PFA) system has received expanded CE mark ...
EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System The Sphere-360 catheter was ...
AMSTERDAM, the Netherlands—For patients with paroxysmal atrial fibrillation (AF), a pulsed-field ablation (PFA) system fared well versus conventional radiofrequency or cryoballoon ablation modalities ...
HAYWARD, Calif., March 12, 2026--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond ...
Pulse Biosciences (Nasdaq:PLSE) today announced clinical findings demonstrating the durability of its nPulse Vybrance system.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results